| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/18/2013 | EP1613272B1 Method for preparation of site-specific protein conjugates |
| 12/18/2013 | EP1507791B1 Antisense antiviral agent and method for treating ssrna viral infection |
| 12/18/2013 | EP1452174B1 Stabilized composition comprising reduced coenzyme q10 |
| 12/18/2013 | EP1439187B1 O2-arylated or o2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and o2-substituted 1- (2-carboxylato)pyrrolidin-1-yl diazen-1-ium-1,2-diolates |
| 12/18/2013 | EP1283704B1 Pharmaceutical compositions for transdermal administration of anti-inflammatory agents |
| 12/18/2013 | CN203342089U Arnebia root oil-immersed spunlace nonwoven fabric paste for external use |
| 12/18/2013 | CN1899277B Composition of rheinic acid or rheinic acid compounds, its preparing method and its use in preparing medicine for treating diabetic nephrosis |
| 12/18/2013 | CN103460050A Marker for determination of sensitivity to anticancer agent |
| 12/18/2013 | CN103460042A Use of glu-tubulin as biomarker of drug response to furazanobenzimidazoles |
| 12/18/2013 | CN103459599A Treatment of NANOG related diseases by inhibition of natural antisense transcript to NANOG |
| 12/18/2013 | CN103459400A Novel imidazo-oxazine compound or salt thereof |
| 12/18/2013 | CN103459399A Tetracyclic indole derivatives for treating hepatitis c virus infection |
| 12/18/2013 | CN103459397A 6-cyclobutyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as PDE9A inhibitors |
| 12/18/2013 | CN103459396A [1, 2, 4] triazolo [4, 3 -b] pyridazine compounds as inhibitors of c-met tyrosine kinase |
| 12/18/2013 | CN103459395A (1,2,4)triazolo[4,3-a]quinoxaline derivatives as inhibitors of phosphodiesterases |
| 12/18/2013 | CN103459394A Crystalline and non-crystalline forms of tofacitinib, and a pharmaceutical composition comprising tofacitinib and a penetration enhancer |
| 12/18/2013 | CN103459392A Process for the production of a pemetrexed salt |
| 12/18/2013 | CN103459390A Macrocyclic integrase inhibitors for use in the treatment of feline immunodeficiency virus |
| 12/18/2013 | CN103459389A 7-(heteroaryl-amino)-6, 7, 8, 9-tetrahydropyrido[1,2-a]indol acetic acid derivatives and their use as prostaglandin d2 receptor modulators |
| 12/18/2013 | CN103459388A Novel furanone derivative |
| 12/18/2013 | CN103459385A IL17 and IFN-[gamma] inhibition for the treatment of autoimmune inflammation |
| 12/18/2013 | CN103459384A Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture |
| 12/18/2013 | CN103459383A Pyrazole compounds |
| 12/18/2013 | CN103459381A 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazole-4-carboxylic acid crystalline form and the producing method thereof |
| 12/18/2013 | CN103459380A Novel phenylpyridine derivative and drug containing same |
| 12/18/2013 | CN103459379A Glycine transport inhibitor |
| 12/18/2013 | CN103459377A Benzo [b] [1, 4] oxazin derivatives as calcium sensing receptor modulators |
| 12/18/2013 | CN103459373A Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds |
| 12/18/2013 | CN103459369A 胍化合物 Guanidine compound |
| 12/18/2013 | CN103459362A A complex of garcinol, cyclodextrin and method thereof |
| 12/18/2013 | CN103459361A 1,5-diphenyl-penta-1,4-dien-3-one compounds |
| 12/18/2013 | CN103458970A Tfeb phosphorylation inhibitors and uses thereof |
| 12/18/2013 | CN103458929A Fat emulsion containing prostaglandin |
| 12/18/2013 | CN103458928A (R)-1,2-propanediol for use as solvent in therapeutic cooling agent compositions |
| 12/18/2013 | CN103458919A Prevention of hypoglycaemia in diabetes mellitus type 2 patients |
| 12/18/2013 | CN103458902A Therapeutic use of a tlr agonist and combination therapy |
| 12/18/2013 | CN103458901A Oral dosage forms for modified release comprising tasocitinib |
| 12/18/2013 | CN103458900A Stable compositions of tetrahydrobiopterin |
| 12/18/2013 | CN103458899A Methods for treating obstructive sleep apnea |
| 12/18/2013 | CN103458898A Autophagy inducing compound and use thereof |
| 12/18/2013 | CN103458897A Pharmaceutical cream compositions of oxymetazoline for treating symptoms of rosacea |
| 12/18/2013 | CN103458896A Methods for treating cancer |
| 12/18/2013 | CN103458895A Compositions of rotigotine, derivatives thereof, or pharmaceutically acceptable salts of rotigotine or its derivative |
| 12/18/2013 | CN103458894A High concentration olopatadine ophthalmic composition |
| 12/18/2013 | CN103458893A Sn-1(3) monoacylglycerides and lipid absorption |
| 12/18/2013 | CN103458892A Composition for topical use for treating skin disorders |
| 12/18/2013 | CN103458891A Nutritional composition |
| 12/18/2013 | CN103458890A Nutritional compositions including branched chain fatty acids and methods of using same |
| 12/18/2013 | CN103458889A Nutritional compositions including branched chain fatty acids for wound healing |
| 12/18/2013 | CN103458888A Nutritional compositions including branched chain fatty acids for improving gut barrier function |
| 12/18/2013 | CN103458887A Nutritional compositions for increasing arginine levels and methods of using same |
| 12/18/2013 | CN103458886A Pyridonyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof |
| 12/18/2013 | CN103458885A Isolated compounds from turmeric oil and methods of use |
| 12/18/2013 | CN103458884A Methods and compositions for treating kidney disorders |
| 12/18/2013 | CN103458883A Viral inhibitor composition for in vivo therapeutic use |
| 12/18/2013 | CN103458882A Bakuchiol compositions for treatment of post inflammatory hyperpigmentation |
| 12/18/2013 | CN103458881A Methods of using ALK inhibitors |
| 12/18/2013 | CN103458880A Unit dose form for oral administration |
| 12/18/2013 | CN103458879A Osmotic mediated release synthetic nanocarriers |
| 12/18/2013 | CN103458878A Solid preparation |
| 12/18/2013 | CN103458877A Immunosuppressant formulations |
| 12/18/2013 | CN103458875A Compositions comprising inhibitors of sodium-glucose cotransporters 1 and 2 and using methods |
| 12/18/2013 | CN103458865A Composition for external application |
| 12/18/2013 | CN103458864A Liquid composition for oral cavity and method for stable addition of components to composition |
| 12/18/2013 | CN103458710A Nutritional compositions having alpha-hica and citrulline |
| 12/18/2013 | CN103458690A Compositions and methods of treating pulmonary hypertension |
| 12/18/2013 | CN103451246A Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
| 12/18/2013 | CN103450468A PEGylated artesunate derivatives, and pharmaceutical compositions and uses thereof |
| 12/18/2013 | CN103450371A Tetrahydro-beta-carbolinyl-3-formacyl-diethylenetriamino-beta-cyclodextrins, and preparation, antithrombotic activity and application thereof |
| 12/18/2013 | CN103450364A High-substitution-degree carboxymethyl starch and composite hydrogel thereof, and preparation method and application of carboxymethyl starch and composite hydrogel thereof |
| 12/18/2013 | CN103450361A Carboxymethyl cellulose grafted polylactic acid amphiphilic polymer, as well as preparation method and application thereof |
| 12/18/2013 | CN103450360A Antibodies to cd40 |
| 12/18/2013 | CN103450339A LRGD peptide-modified carbolino-hexahydropyrazine-1,4-diketones and their preparation method, antithrombotic effect and use |
| 12/18/2013 | CN103450337A TRGD peptide-modified carbolino-hexahydropyrazine-1,4-diketones and their preparation method, antithrombotic effect and use |
| 12/18/2013 | CN103450336A KRGD peptide-modified carbolino-hexahydropyrazine-1,4-diketones and their preparation method, antithrombotic effect and use |
| 12/18/2013 | CN103450334A RGD peptide-modified carbolino-hexahydropyrazine-1,4-diketones and their preparation method, antithrombotic effect and use |
| 12/18/2013 | CN103450325A Tanshinone II A sulfonate, preparation method, and applications thereof |
| 12/18/2013 | CN103450323A Radix ophiopogonis nerve growth factor activity simulating component and compound and preparation |
| 12/18/2013 | CN103450321A Nortriterpene compound as well asand preparation method and application thereof |
| 12/18/2013 | CN103450314A Plant extract with anti-tumor activity and active ingredients thereof |
| 12/18/2013 | CN103450312A New crystal form of vecuronium bromide, and preparation method and use thereof |
| 12/18/2013 | CN103450311A New crystal form of vecuronium bromide, and preparation method and use thereof |
| 12/18/2013 | CN103450310A Stigmasterol derivative and application thereof in preparation of anti-cancer drug |
| 12/18/2013 | CN103450308A Compounds, extracting method thereof, pharmaceutical composition containing compounds and application of compounds and pharmaceutical composition |
| 12/18/2013 | CN103450304A Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives |
| 12/18/2013 | CN103450301A Farnesyl thiosalicylic acid-nucleoside conjugate as well as preparation method and medical application thereof |
| 12/18/2013 | CN103450290A Feruloyl oligosaccharides and preparation method and application thereof |
| 12/18/2013 | CN103450281A 1-azabenzanthrone-platinum (II) complex as well as synthesis method and application thereof |
| 12/18/2013 | CN103450278A Water-soluble carbon monoxide releasing molecule and preparation method and application thereof |
| 12/18/2013 | CN103450258A Salts of alkoxyl pyrimidine derivatives |
| 12/18/2013 | CN103450253A Dibutyltin4-nitrobenzoate in trapezoid structure as well as preparation method and application thereof |
| 12/18/2013 | CN103450252A Dibutyltin alpha-naphthylacetate having tin-containing oxygen heterocyclic structure and preparation method and application thereof |
| 12/18/2013 | CN103450241A Borate compound and medicine composition thereof |
| 12/18/2013 | CN103450236A 6-Hydroxyloxoisoaporphine rare earth complexes, and synthetic method and application thereof |
| 12/18/2013 | CN103450221A Alpha helix mimetics and methods relating thereto |
| 12/18/2013 | CN103450220A Novel nitroimidazole compound and application thereof in pharmacy |
| 12/18/2013 | CN103450218A Indole tricyclic derivative as CRTH2 receptor antagonist |
| 12/18/2013 | CN103450214A Glucopyranesyl derivative, preparation method thereof and application thereof in medicines |
| 12/18/2013 | CN103450209A Isoflavonoid compound in ficus auriculata, as well as preparation method and application thereof |
| 12/18/2013 | CN103450208A Antibacterial compound as well as preparation method and application thereof |